4//SEC Filing
Malabre Richard C 4
Accession 0001562180-25-004491
CIK 0001517022other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:35 PM ET
Size
5.1 KB
Accession
0001562180-25-004491
Insider Transaction Report
Form 4
Malabre Richard C
SVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-06-04$3.53/sh−13,334$47,069→ 266,914 total
Footnotes (2)
- [F1]This sale was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the Reporting Person on December 12, 2024.
- [F2]The shares were sold at prices ranging from $3.50 to $3.60 and the price reported reflects the weighted average sale price.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0002007730
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:35 PM ET
- Size
- 5.1 KB